PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Gustave Roussy Cancer Center, Villejuif, France.\', \'Faculty of Medicine, Université Paris Saclay, Le Kremlin-Bicêtre, France.\', \'INSERM U1015, Villejuif, France.\', \'Aix-Marseille University, IRD, APHM, MEPHI, Marseille, France.\', \'IHU-Méditerranée Infection, Marseille, France.\', \'Département de Biologie, Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France.\', \'Unité de Pathologie Infectieuse, Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France.\', \'Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France.\', \'Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France.\', \'Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.\', \'Karolinska Institute, Department of Women\'s and Children\'s Health, Karolinska University Hospital, Stockholm, Sweden.\', \'Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China.\', \'Gustave Roussy Cancer Center, Villejuif, France. laurence.zitvogel@gustaveroussy.fr.\', \'Faculty of Medicine, Université Paris Saclay, Le Kremlin-Bicêtre, France. laurence.zitvogel@gustaveroussy.fr.\', \'INSERM U1015, Villejuif, France. laurence.zitvogel@gustaveroussy.fr.\', \'Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China. laurence.zitvogel@gustaveroussy.fr.\', \'Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. laurence.zitvogel@gustaveroussy.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s43018-020-00122-3
?:doi
?:hasPublicationType
?:journal
  • Nature cancer
is ?:pmid of
?:pmid
?:pmid
  • 35121872
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • The immuno-oncological challenge of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all